Loading
Loading…
Loading…
| # | Company | Rank | Status |
|---|---|---|---|
| 1 | NAAccepted-Finance | NA | Accepted-Finance Please see the list of finalised items |
| 2 | NAAccepted-Finance | NA | Accepted-Finance Please see the list of finalised items |
| 3 | NAAccepted-Finance | NA | Accepted-Finance Please see the list of finalised items |
| 4 | NAAccepted-Finance | NA | Accepted-Finance Please see the list of finalised items |
| 5 | NAAccepted-Finance | NA | Accepted-Finance Please see the list of finalised items |
| Sl No | Description | Qty | Unit | Eli Lilly and Company (India) Pvt. Ltd. | MSD PHARMACEUTICALS PVT LIMITED | Astellas Pharma India Pvt Ltd | ASTRAZENECA PHARMA INDIA LIMITED | Intas Pharmaceuticals Ltd. | Novartis Healthcare Pvt Ltd | Novartis India Ltd. | Johnson and Johnson Private Limited | Gennova Biopharmaceuticals Limited | Cipla Ltd. | Fresenius Kabi India Pvt Ltd | Merck Specialities Private Limited | CADILA PHARMACEUTICALS LIMITED | BDR PHARMACEUTICALS INTL PVT LTD | GLENMARK PHARMACEUTICALS LIMITED | Takeda Biopharmaceuticals India Private Limited | Biocon Biologics Limited | AbbVie Healthcare India Private Ltd | Pfizer Limited | Bayer Pharmaceutical Pvt. Ltd. | IDRS Labs Pvt Ltd | SERVIER INDIA PRIVATE LIMITED (FORMERLY KNOWN AS SERDIA PHARMACEUTICALS INDIA PVT LTD) | ROCHE PRODUCTS INDIA PVT LTD | Pfizer Products India Pvt. Ltd | Bristol Myers Squibb India Private Limited | Dr Reddys Laboratories Limited |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00Name of items : | |||||||||||||||||||||||||||||
| 1.01 | ABEMACICLIB | 1 | 100 MG | 35,81,390.4 ₹40.1 L | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 1.02 | ABEMACICLIB | 1 | 150 MG | 2,50,69,732.8 ₹2.8 Cr | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 1.03 | ALECTINIB | 1 | 150 MG | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 19,96,20,960 ₹22.4 Cr | - | - | - |
| 1.04 | ALPELISIB | 1 | 150 MG | - | - | - | - | - | 27,41,841 ₹30.7 L | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 1.05 | ALTEPLASE | 1 | 50 MG | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 1.06 | AMIVANTAMAB | 1 | 350 MG | - | - | - | - | - | - | - | 1,48,42,306.24 ₹1.7 Cr | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 1.07 | ASCIMINIB | 1 | 40 MG | - | - | - | - | - | 34,02,364.98 ₹38.1 L | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 1.08 | ATEZOLIZUMAB | 1 | 1200 MG | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 17,03,01,930 ₹19.1 Cr | - | - | - |
| 1.09 | AVELUMAB | 1 | 200 MG | - | - | - | - | - | - | - | - | - | - | - | 1,06,49,595 ₹1.2 Cr | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Tender Value
₹320 Cr
EMD Value
₹5 L
Closing Date
22 Jul 2025, 3:00 pmClosed
Dr Sudeep Gupta,Director TMC
TMH, Parel, Mumbai
Tender for Innovator/Original Drugs
2025_TMC_863673_1
TMC/DRUGRC/P/2025-27/13
Open Tender
Drugs and Pharmaceutical Products
TMH PAREL Mumbai
Please refer Tender documents.
4 documents required · 4 mandatory
₹0
₹5 L
Yes
3 Nov 2025
11 Jun 2025
23 Jul 2025
11 Jun 2025
22 Jul 2025
17 Jun 2025
11 Jun 2025 - 13 Jun 2025
Name of items :
ABEMACICLIB
ABEMACICLIB
ALECTINIB
ALPELISIB
ALTEPLASE
AMIVANTAMAB
ASCIMINIB
ATEZOLIZUMAB
AVELUMAB
BRENTUXIMAB VEDOTIN
CAPECITABINE+CYCLOPHOSPHAMIDE
CAPECITABINE+CYCLOPHOSPHAMIDE
CAPMATINIB
CARMUSTINE
CLADRIBINE
DABRAFENIB
DABRAFENIB
DACOMITINIB
DACOMITINIB
DARATUMUMAB + HYALURONIDASE-FIHJ
DAROLUTAMIDE
DOCETAXEL NANOSOMAL(LIPID SUSPENSION)
DOCETAXEL NANOSOMAL(LIPID SUSPENSION)
DOCETAXEL NANOSOMAL(LIPID SUSPENSION)
DURVALUMAB
DURVALUMAB
ENFORTUMAB VEDOTIN
ENFORTUMAB VEDOTIN
ENTRECTINIB
ENTRECTINIB
ENZALUTAMIDE
FACTOR VII EPTACOG ALFA(HUMAN RECOMBINANT COAGULATION FACTOR VII ACTIVATED r-DNA ORIGIN)
FACTOR VII EPTACOG ALFA(HUMAN RECOMBINANT COAGULATION FACTOR VII ACTIVATED r-DNA ORIGIN)
FOSFESTROL
FOSNETUPITANT+PALONOSETRON
GILTERITINIB
GLOFITAMAB
GLOFITAMAB
GOSERELIN
GOSERELIN
IDARUBICIN
IMATINIB
IMATINIB
INOTUZUMAB
IPILIMUMAB
IRINOTECAN LIPOSOMAL
ISAVUCONAZOLE
ISAVUCONAZOLE
LEUPROLIDE ACETATE
LORLATINIB
LORLATINIB
LUSPATERCEPT
LUSPATERCEPT
MERCAPTOPURINE
MEROPENEM
MEROPENEM
MYCOBACTERIUM W.(HEAT KILLED) IMMUNOMODULATOR
NANOSOMAL PACLITAXEL LIPID SUSPENSION
NANOSOMAL PACLITAXEL LIPID SUSPENSION
NIMOTUZUMAB
NINTEDANIB
NINTEDANIB
OBINUTUZUMAB
OSIMERTINIB
OSIMERTINIB
PACLITAXEL NANOPARTICLE
PALANOSETRON+NETUPITANT(COMBIPACK)
PANITUMUMAB
PEGASPARGASE
PEMBROLIZUMAB
PERTUZUMAB+TRASTUZUMAB
PERTUZUMAB+TRASTUZUMAB
POLATUZUMAB VEDOTIN
RAMUCIRUMAB
RAMUCIRUMAB
RIBOCICLIB
RUXOLITINIB
RUXOLITINIB
RUXOLITINIB
RUXOLITINIB
SODIUM COPPER CHLOROPHYLLIN
SODIUM COPPER CHLOROPHYLLIN
TECLISTAMAB
TECLISTAMAB
TEPOTINIB
THYROTROPIN ALFA
TOCILIZUMAB
TOCILIZUMAB
TOCILIZUMAB
TORIPALIMAB
TRAMETINIB
TRAMETINIB
TRASTUZUMAB DERUXTECAN
TREMELIMUMAB
TRIPTORELIN
TRIPTORELIN
TRIPTORELIN
VENETOCLAX
VENETOCLAX
VENETOCLAX
VORICONAZOLE
VORICONAZOLE
VORICONAZOLE
Bidder Name
Cipla Ltd.
GLENMARK PHARMACEUTICALS LIMITED
Johnson and Johnson Private Limited
Eli Lilly and Company (India) Pvt. Ltd.
ASTRAZENECA PHARMA INDIA LIMITED
Intas Pharmaceuticals Ltd.
Novartis India Ltd.
Novartis Healthcare Pvt Ltd
BDR PHARMACEUTICALS INTL PVT LTD
Fresenius Kabi India Pvt Ltd
ROCHE PRODUCTS INDIA PVT LTD
CADILA PHARMACEUTICALS LIMITED
Gennova Biopharmaceuticals Limited
Astellas Pharma India Pvt Ltd
MSD PHARMACEUTICALS PVT LIMITED
Merck Specialities Private Limited
Pfizer Products India Pvt. Ltd
Pfizer Limited
Bristol Myers Squibb India Private Limited
Biocon Biologics Limited
Dr Reddys Laboratories Limited
Takeda Biopharmaceuticals India Private Limited
Bayer Pharmaceutical Pvt. Ltd.
SERVIER INDIA PRIVATE LIMITED (FORMERLY KNOWN AS SERDIA PHARMACEUTICALS INDIA PVT LTD)
IDRS Labs Pvt Ltd
AbbVie Healthcare India Private Ltd
MSD PHARMACEUTICALS PVT LIMITED
Astellas Pharma India Pvt Ltd
ASTRAZENECA PHARMA INDIA LIMITED
AbbVie Healthcare India Private Ltd
Bristol Myers Squibb India Private Limited
Intas Pharmaceuticals Ltd.
Novartis Healthcare Pvt Ltd
Novartis India Ltd.
Bayer Pharmaceutical Pvt. Ltd.
Pfizer Products India Pvt. Ltd
IDRS Labs Pvt Ltd
Pfizer Limited
Johnson and Johnson Private Limited
SERVIER INDIA PRIVATE LIMITED (FORMERLY KNOWN AS SERDIA PHARMACEUTICALS INDIA PVT LTD)
Dr Reddys Laboratories Limited
Merck Specialities Private Limited
Gennova Biopharmaceuticals Limited
Cipla Ltd.
Fresenius Kabi India Pvt Ltd
Takeda Biopharmaceuticals India Private Limited
CADILA PHARMACEUTICALS LIMITED
ROCHE PRODUCTS INDIA PVT LTD
Biocon Biologics Limited
BDR PHARMACEUTICALS INTL PVT LTD
GLENMARK PHARMACEUTICALS LIMITED
stage.html
html • 0.12 MB
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
BOQ.xls
BOQ • 0.41 MB
BOQ_2.xls
BOQ • 0.06 MB
Tenderdocument.pdf
Tender Documents • 1.11 MB
Download all tender documents and submit your bid